MARKETS

BSE Prices delayed by 5 minutes... Prices as on Jun 19, 2018 - 10:05AM   ABB India 1195.05 [ -1.63% ]ACC 1289.9 [ -0.73% ]Ambuja Cements Ltd. 202 [ -0.69% ]Asian Paints Ltd. 1281.4 [ 0.37% ]Axis Bank Ltd. 519.7 [ -0.45% ]Bajaj Auto Ltd. 2879.2 [ -0.78% ]Bank of Baroda 131.25 [ 0.27% ]Bharti Airtel 373.85 [ 0.70% ]Bharat Heavy Ele 76.15 [ 0.26% ]Bharat Petroleum 412.25 [ -2.53% ]Britannia Ind. 6030.15 [ -0.76% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 608.5 [ 0.41% ]Coal India Ltd. 273.85 [ -0.27% ]Colgate Palm. 1195.2 [ -0.66% ]Dabur India 384.55 [ -0.45% ]DLF Ltd. 200.3 [ 0.28% ]Dr. Reddy's Labs 2418.9 [ 1.62% ]GAIL (India) Ltd. 341.75 [ 1.05% ]Grasim Inds. 1002.45 [ -1.76% ]HCL Technologies 923.7 [ -1.07% ]HDFC 1817 [ -0.42% ]HDFC Bank 2023 [ 0.08% ]Hero MotoCorp 3629.55 [ -1.07% ]Hindustan Unilever L 1596 [ -0.86% ]Hindalco Indus. 230.5 [ -0.30% ]ICICI Bank 291.65 [ -0.29% ]IDFC L 49.1 [ -0.61% ]Indian Hotels Co 133.85 [ -0.63% ]IndusInd Bank 1953.5 [ -0.72% ]Infosys 1243 [ -1.86% ]ITC Ltd. 263.75 [ -0.15% ]Jindal St & Pwr 230.7 [ 0.52% ]Kotak Mahindra Bank 1315 [ 0.07% ]L&T 1318.5 [ -0.35% ]Lupin Ltd. 915.45 [ 1.46% ]Mahi. & Mahi 911 [ -0.19% ]Maruti Suzuki India 8925 [ -0.76% ]MTNL 17.15 [ -0.29% ]Nestle India 9649 [ 0.26% ]NIIT Ltd. 98.4 [ -1.20% ]NMDC Ltd. 112.1 [ -0.22% ]NTPC 155.15 [ -0.99% ]ONGC 165 [ 0.40% ]Punj. NationlBak 89.3 [ 1.02% ]Power Grid Corpo 198.05 [ -0.43% ]Reliance Inds. 1013 [ -0.20% ]SBI 275.8 [ -0.38% ]Vedanta 228 [ -1.85% ]Shipping Corpn. 64.35 [ 0.08% ]Sun Pharma. 573.75 [ 0.51% ]Tata Chemicals 728.8 [ -0.67% ]Tata Global Beverage 269.65 [ -1.87% ]Tata Motors Ltd. 310.25 [ 0.49% ]Tata Steel 562.45 [ 0.67% ]Tata Power Co. 74.75 [ -0.60% ]Tata Consultancy 1831 [ 0.02% ]Tech Mahindra Ltd. 706.6 [ -0.46% ]UltraTech Cement 3634 [ -0.96% ]United Spirits 675 [ 1.28% ]Wipro Ltd 262.2 [ -1.28% ]Zee Entertainment En 557 [ -0.68% ]

News Details

You can view in detail.
Cipla bags approval for Isoproterenol Hydrochloride Injection 14/06/2018 09:26

Cipla Limited (“Cipla”), has said that it has received final approval for its Abbreviated New Drug Application (ANDA) for Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, single - use sterile Ampoule from the United States Food and Drug Administration (US FDA ).

Cipla’s Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, ampoule is AP - rated generic therapeutic equivalent version of Hospira Inc’s Isuprel ® Injection, 0.2mg/m.

According to IQVIA (IMS Health), Isuprel Injection and its generic equivalents had US sales of approximately USD 1 48 M for the 12-month period ending April 2018.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Meanwhile, shares of the company were trading at Rs 589.30 apiece up 1.36 per cent from the previous close at 09:28 hrs on BSE.

LOAD MORE